Previous studies have shown that protein kinase C (PKC) activators and dibutyryl cyclic AMP (Bt2cAMP) synergistically increase the antigen level of plasminogen activator inhibitor type-2 (PAI-2) in a human myeloid leukemia cell line PL-21. To clarify the mechanism, PAI-2 gene expression induced by phorbol myristate acetate (PMA), a PKC activator, and Bt2cAMP was investigated by Northern blot hybridization using a PAI-2 cDNA probe cloned from a human placental library. The level of PAI-2 mRNA was markedly increased in response to PMA and reached a maximum 5-9 h after stimulation. Nuclear run-on assay revealed an increase in PAI-2 gene transcription in PMA-treated cells. The induction was inhibited by inhibiting de novo protein synthesis with cycloheximide (CHX). cAMP also increased PAI-2 mRNA level in a dose-dependent manner. The increase began within 2 hours and, contrary to the case of PMA, the mRNA levels were maintained. Moreover, cAMP-induced increase in PAI-2 mRNA was not inhibited by CHX, rather enhanced. PMA and cAMP synergistically induced PAI-2 gene expression, which was completely inhibited by CHX. The cells pretreated with PMA for 24 h did not any more respond to stimulation with PMA but responded to cAMP and PAI-2 mRNA level was increased. The apparent half-life of constitutive level PAI-2 mRNA in PL-21 cells, determined by actinomycin-D-decay experiments, was approximately 2 h. Those induced by PMA and cAMP were approximately 5 h and 2 h, respectively. These data suggest that PAI-2 mRNA induced by PMA is relatively stable and the expression requires de novo protein synthesis, whereas cAMP increases PAI-2 mRNA level without affecting the stability and the induction does not require de novo protein synthesis. Judging from these data, PAI-2 gene expression appears to be differently regulated by the PKC and cAMP signalling pathways.
References
1
Carrell R,
Travis J.
α2-antitrypsin and the serpins: Variation and countervariation. Trends Biochem Sci 1985; 10: 20-24
2
Kruithof EKO,
Vassalli J,
Schleuning W,
Mattaliano RJ,
Bachmann F.
Purification and characterization of a plasminogen activator inhibitor from the histiocytic lymphoma cell line U-937. J Biol Chem 1986; 261: 11207-11213
3
Alving BM,
Krishnamurti C,
Liu YP,
Lucas DL,
Wright DG.
Stimulated production of urokinase and plasminogen activator inhibitor-2 by the human promyelocytic leukemia cell line HL-60. Thromb Res 1988; 51: 175-185
6
Rehemtulla A,
Arndt A,
Hart DA.
Induction of plasminogen activator inhibitor type 2 expression during differentiation of human K562 cells towards a macrophage phenotype. Biochem Cell Biol 1990; 68: 1337-1343
7
Takeuchi T,
Niiya K,
Kubonishi I,
Miyoshi I.
A plasminogen activator inhibitor-2 from a promyelocytic leukemia cell line, PL-21, binds to the car-boxy-terminal chain of plasminogen activators. Thromb Haemost 1990; 63: 259-264
8
Kubonishi I,
Ohtsuki Y,
Miyagi T,
Yoshimoto S,
Akagi T,
Miyoshi I.
Electron microscopic and immunohistochemical observations of differentiation of human myeloid leukemia line, PL-21. J Cancer Res Clin Oncol 1986; 111: 203-208
9
Aihara H,
Asaoka Y,
Yoshida K,
Nishizuka Y.
Sustained activation of protein kinase C is essential to HL-60 cell differentiation to macrophage. Proc Natl Acad Sci USA 1991; 88: 11062-11066
10
Stone RM,
Weber BL,
Spriggs DR,
Kufe DW.
Phospholipase C activates protein kinase C and induces monocytic differentiation of HL-60 cells. Blood 1988; 72: 739-744
12
Genton C,
Kruithof EK,
Schleuning WD.
Phorbol ester induces the biosynthesis of glycosylated and nonglycosylated plasminogen activator inhibitor 2 in high excess over urokinase-type plasminogen activator in human U-937 lymphoma cells. J Cell Biol 1987; 104: 705-712
14
Antalis TM,
Dickinson JL.
Control of plasminogen-activator inhibitor type 2 gene expression in the differentiation of monocytic cells. Eur J Biochem 1992; 205: 203-209
15
Cousin E,
Medcalf RL,
Bergonzelli GE,
Kruithof EK.
Regulatory elements involved in constitutive and phorbol ester-inducible expression of the plasminogen activator inhibitor type 2 gene promoter. Nucleic Acids Res 1991; 19: 3881-3886
16
Niiya K,
Takeuchi T,
Kobayashi M,
Miyoshi I,
Hayashi T,
Sakuragawa N.
Dexamethasone and phorbol ester, but not cytokines, increase the production of plasminogen activator inhibitor type-2 in the PL-21 human promyelocytic leukemia cell line. Thromb Haemost 1991; 66: 232-238
17
Hayashi T,
Niiya K,
Hirokawa S,
Sakuragawa N.
Synergistic stimulating effect between cyclic AMP and phorbol ester on plasminogen activator inhibitor type 2 production in human promyelocytic leukemia cell line PL-21. Biochim Biophys Acta 1992; 1134: 273-277
20
Ye RD,
Ahem SM,
Le-Beau MM,
Lebo RV,
Sadler JE.
Structure of the gene for human plasminogen activator inhibitor-2. The nearest mammalian homologue of chicken ovalbumin. J Biol Chem 1989; 264: 5495-5502
23
Heller R,
Bussolino F,
Ghigo D,
Garbarino G,
Schroder H,
Pescarmona G,
Till U,
Bosia A.
Protein kinase C and cyclic AMP modulate thrombin-induced platelet-activating factor synthesis in human endothelial cells. Biochim Biophys Acta 1991; 1093: 55-64
26
Pytel BA,
Peppel K,
Baglioni C.
Plasminogen activator inhibitor type-2 is a major protein induced in human fibroblasts and SK-MEL-109 melanoma cells by tumor necrosis factor. J Cell Physiol 1990; 144: 416-422
30
Chiu R,
Boyle WJ,
Meek J,
Smeal T,
Hunter T,
Karin M.
The c-Fos protein interacts with c-Jun/AP-1 to stimulate transcription of AP-1 responsive genes. Cell 1988; 54: 541-552
32
Halazonetis TD,
Georgopoulos K,
Greenberg ME,
Leder P.
c-Jun dimerizes with itself and with c-Fos, forming complexes of different DNA binding affinities. Cell 1988; 55: 917-924
33
Boyle WJ,
Smeal T,
Defize LH,
Angel P,
Woodgett JR,
Karin M,
Hunter T.
Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity. Cell 1991; 64: 573-584
35
Ohsawa K,
Hyakawa Y,
Nishizawa M,
Yamagami T,
Yamamoto H,
Yanaihara N,
Okamoto H.
Synergistic stimulation of VIP/PHM-27 gene expression by cyclic AMP and phorbol esters in human neuroblastoma cells. Biochem Biophys Res Commun 1985; 132: 885-891
36
Fink JS,
Verhave M,
Walton K,
Mandel G,
Goodman RH.
Cyclic AMP-and phorbol ester-induced transcriptional activation are mediated by the same enhancer element in the human vasoactive intestinal peptide gene. J Biol Chem 1991; 266: 3882-3887
